Naloxone (Narcan) dispensing without a prescription is now authorized in all 50 states in some form, following a mix of state legislation, standing orders, and the FDA’s 2023 OTC approval of Narcan 4mg nasal spray.
FDA OTC approval
In March 2023, the FDA approved Narcan 4mg nasal spray for OTC sale. However, branded OTC naloxone is more expensive than prescription naloxone, and many patients continue to access naloxone through pharmacy dispensing under state programs.
State standing orders
Most states have statewide standing orders that allow pharmacists to dispense naloxone to patients without an individual prescription. These are typically issued by the state health department or surgeon general.
Counseling requirements
Many states require pharmacists to provide counseling when dispensing naloxone — covering how to recognize an overdose, how to administer naloxone, and when to call 911. Know your state’s requirements before dispensing.
Illinois Standard Procedures
Illinois published specific Standard Procedures for Naloxone Distribution that detail exactly what pharmacists must do when dispensing naloxone under the statewide standing order. A useful reference for understanding how states structure these requirements.
Reimbursement
Naloxone dispensing reimbursement varies by state and payer. Many state Medicaid programs cover naloxone without cost-sharing. Verify current reimbursement policies with your state pharmacy association.